189 related articles for article (PubMed ID: 31679182)
1. Magnetic resonance image-guided focal laser ablation in clinically localized prostate cancer: safety and efficacy.
Al-Hakeem Y; Raz O; Gacs Z; Maclean F; Varol C
ANZ J Surg; 2019 Dec; 89(12):1610-1614. PubMed ID: 31679182
[TBL] [Abstract][Full Text] [Related]
2. Phase II Evaluation of Magnetic Resonance Imaging Guided Focal Laser Ablation of Prostate Cancer.
Eggener SE; Yousuf A; Watson S; Wang S; Oto A
J Urol; 2016 Dec; 196(6):1670-1675. PubMed ID: 27449263
[TBL] [Abstract][Full Text] [Related]
3. Complications, Recovery, and Early Functional Outcomes and Oncologic Control Following In-bore Focal Laser Ablation of Prostate Cancer.
Lepor H; Llukani E; Sperling D; Fütterer JJ
Eur Urol; 2015 Dec; 68(6):924-6. PubMed ID: 25979568
[TBL] [Abstract][Full Text] [Related]
4. Focal Laser Ablation of Prostate Cancer: Results in 120 Patients with Low- to Intermediate-Risk Disease.
Walser E; Nance A; Ynalvez L; Yong S; Aoughsten JS; Eyzaguirre EJ; Williams SB
J Vasc Interv Radiol; 2019 Mar; 30(3):401-409.e2. PubMed ID: 30819483
[TBL] [Abstract][Full Text] [Related]
5. Two-year Outcomes Following Focal Laser Ablation of Localized Prostate Cancer.
Chao B; Llukani E; Lepor H
Eur Urol Oncol; 2018 Jun; 1(2):129-133. PubMed ID: 31100236
[TBL] [Abstract][Full Text] [Related]
6. MRI Findings After MRI-Guided Focal Laser Ablation of Prostate Cancer.
Westin C; Chatterjee A; Ku E; Yousuf A; Wang S; Thomas S; Fan X; Eggener S; Karczmar G; Oto A
AJR Am J Roentgenol; 2018 Sep; 211(3):595-604. PubMed ID: 29995499
[TBL] [Abstract][Full Text] [Related]
7. Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer.
Alberts AR; Roobol MJ; Drost FH; van Leenders GJ; Bokhorst LP; Bangma CH; Schoots IG
BJU Int; 2017 Oct; 120(4):511-519. PubMed ID: 28267899
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance guided focused high frequency ultrasound ablation for focal therapy in prostate cancer - phase 1 trial.
Ghai S; Perlis N; Lindner U; Hlasny E; Haider MA; Finelli A; Zlotta AR; Kulkarni GS; van der Kwast TH; McCluskey SA; Kucharczyk W; Trachtenberg J
Eur Radiol; 2018 Oct; 28(10):4281-4287. PubMed ID: 29696431
[TBL] [Abstract][Full Text] [Related]
9. MR imaging-guided focal laser ablation for prostate cancer: phase I trial.
Oto A; Sethi I; Karczmar G; McNichols R; Ivancevic MK; Stadler WM; Watson S; Eggener S
Radiology; 2013 Jun; 267(3):932-40. PubMed ID: 23440319
[TBL] [Abstract][Full Text] [Related]
10. Utility of Multiparametric MRI for Predicting Residual Clinically Significant Prostate Cancer After Focal Laser Ablation.
Felker ER; Raman SS; Lu DSK; Tuttle M; Margolis DJ; ElKhoury FF; Sayre J; Marks LS
AJR Am J Roentgenol; 2019 Dec; 213(6):1253-1258. PubMed ID: 31361529
[No Abstract] [Full Text] [Related]
11. Prostate cancer treatment by the latest focal HIFU device with MRI/TRUS-fusion control biopsies: A prospective evaluation.
von Hardenberg J; Westhoff N; Baumunk D; Hausmann D; Martini T; Marx A; Porubsky S; Schostak M; Michel MS; Ritter M
Urol Oncol; 2018 Sep; 36(9):401.e1-401.e9. PubMed ID: 30093211
[TBL] [Abstract][Full Text] [Related]
12. Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study.
Ahmed HU; Hindley RG; Dickinson L; Freeman A; Kirkham AP; Sahu M; Scott R; Allen C; Van der Meulen J; Emberton M
Lancet Oncol; 2012 Jun; 13(6):622-32. PubMed ID: 22512844
[TBL] [Abstract][Full Text] [Related]
13. Prostate Radiofrequency Focal Ablation (ProRAFT) Trial: A Prospective Development Study Evaluating a Bipolar Radiofrequency Device to Treat Prostate Cancer.
Orczyk C; Barratt D; Brew-Graves C; Peng Hu Y; Freeman A; McCartan N; Potyka I; Ramachandran N; Rodell R; Williams NR; Emberton M; Ahmed HU
J Urol; 2021 Apr; 205(4):1090-1099. PubMed ID: 33315505
[TBL] [Abstract][Full Text] [Related]
14. MRI-guided focal laser ablation of prostate cancer: a prospective single-arm, single-center trial with 3 years of follow-up.
Mehralivand S; George AK; Hoang AN; Rais-Bahrami S; Rastinehad AR; Lebastchi AH; Ahdoot M; Siddiqui MM; Bloom J; Sidana A; Merino MJ; Choyke PL; Shih JH; Turkbey B; Wood BJ; Pinto PA
Diagn Interv Radiol; 2021 May; 27(3):394-400. PubMed ID: 34003127
[TBL] [Abstract][Full Text] [Related]
15. Focal Therapy for Prostate Cancer with In-Bore MR-guided Focused Ultrasound: Two-Year Follow-up of a Phase I Trial-Complications and Functional Outcomes.
Tay KJ; Cheng CWS; Lau WKO; Khoo J; Thng CH; Kwek JW
Radiology; 2017 Nov; 285(2):620-628. PubMed ID: 28654336
[TBL] [Abstract][Full Text] [Related]
16. Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Tissue in Patients with Localized Prostate Cancer: A Prospective Phase 1 Clinical Trial.
Chin JL; Billia M; Relle J; Roethke MC; Popeneciu IV; Kuru TH; Hatiboglu G; Mueller-Wolf MB; Motsch J; Romagnoli C; Kassam Z; Harle CC; Hafron J; Nandalur KR; Chronik BA; Burtnyk M; Schlemmer HP; Pahernik S
Eur Urol; 2016 Sep; 70(3):447-55. PubMed ID: 26777228
[TBL] [Abstract][Full Text] [Related]
17. Focal Laser Ablation of Prostate Cancer: Phase I Clinical Trial.
Natarajan S; Raman S; Priester AM; Garritano J; Margolis DJ; Lieu P; Macairan ML; Huang J; Grundfest W; Marks LS
J Urol; 2016 Jul; 196(1):68-75. PubMed ID: 26748164
[TBL] [Abstract][Full Text] [Related]
18. Image-guided Irreversible Electroporation of Localized Prostate Cancer: Functional and Oncologic Outcomes.
Collettini F; Enders J; Stephan C; Fischer T; Baur ADJ; Penzkofer T; Busch J; Hamm B; Gebauer B
Radiology; 2019 Jul; 292(1):250-257. PubMed ID: 31161973
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of tumor coverage after MR-guided prostate focal laser ablation therapy.
Knull E; Oto A; Eggener S; Tessier D; Guneyli S; Chatterjee A; Fenster A
Med Phys; 2019 Feb; 46(2):800-810. PubMed ID: 30447155
[TBL] [Abstract][Full Text] [Related]
20. Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years.
Bahn D; de Castro Abreu AL; Gill IS; Hung AJ; Silverman P; Gross ME; Lieskovsky G; Ukimura O
Eur Urol; 2012 Jul; 62(1):55-63. PubMed ID: 22445223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
